André Costa Meireles

André Costa Meireles

Auto-generated profile, based on publicly available information

André Costa Meireles

Aliança D’Or Hospital, Salvador 41920-180, BA, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
SMSibelle Botogosque Mattar
Sibelle Botogosque Mattar
PCPaola Celedon
Paola Celedon
Leonardo Maia LeonyLeonardo Maia Leony
Leonardo Maia Leony
LVLarissa Vasconcelos
Larissa Vasconcelos
DSDaniel Dias Sampaio
Daniel Dias Sampaio
Fred SantosFred Santos
Fred Santos
COVID-19 laboratory diagnosis primarily relies on molecular tests, highly sensitive during early infection stages with high viral loads. As the disease progresses, sensitivity decreases, requiring antibody detection. Since the beginning of the pandemic, serological tests have been developed and made available in Brazil, but their diagnostic performance varies. This study evaluated the IBMP ELISA IgA/IgM/IgG COVID-19 kit performance in detecting SARS-CoV-2 antibodies. A total of 90 samples, including 64 from COVID-19 patients and 26 pre-pandemic donors, were assessed based on time post symptom onset (0–7, 8–14, and 15–21 days). The kit showed 61% sensitivity, 100% specificity, and 72% accuracy overall. Sensitivity varied with time, being 25%, 57%, and 96% for 0–7, 8–14, and 15–21 days, respectively. Similar variations were noted in other commercial tests. The Gold ELISA COVID-19 (IgG/IgM) had sensitivities of 31%, 71%, and 100%, while the Anti-SARS-CoV-2 NCP ELISA (IgG) and Anti-SARS-CoV-2 NCP ELISA (IgM) showed varying sensitivities. The IBMP ELISA kit displayed high diagnostic capability, especially as the disease progressed, complementing COVID-19 diagnosis. Reproducibility assessment revealed minimal systematic and analytical errors. In conclusion, the IBMP ELISA IgA/IgM/IgG COVID-19 kit is a robust tool for detecting anti-SARS-CoV-2 antibodies, increasing in efficacy over the disease course, and minimizing false negatives in RT-PCR COVID-19 diagnosis.

28 January 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MVMateus dos Santos Viana
Mateus dos Santos Viana
TSThomaz Emanoel Azevedo Silva
Thomaz Emanoel Azevedo Silva
GBGabriela Oliveira Bagano
Gabriela Oliveira Bagano
BPBruna de Sá Barreto Pontes
Bruna de Sá Barreto Pontes
MMMilton Henrique Vitoria de Melo
Milton Henrique Vitoria de Melo
LCLuis Claudio Lemos Correia
Luis Claudio Lemos Correia
Introduction Coronary anatomy is one of the strongest risk predictors in Acute Coronary Syndromes (ACS), which justifies early coronary angiography. Diagnostic scores for predicting outcomes are usually superior to clinical judgment. Despite being validated for prognosis, the GRACE score has been used to discriminate patients with high or low probability of anatomical severity. Objective To test the hypothesis that the GRACE score actually predicts anatomical severity. Methods The study was carried out by assessing consecutive patients with ACS who underwent invasive angiography. Severe anatomical disease was defined as obstructive involvement (≥ 70% in diameter) in (1) left main coronary artery or (2) double or triple vessel disease involving proximal left anterior descending artery or (3) subocclusion. The GRACE score was evaluated under numerical and dichotomous tests. Results A total of 733 patients were evaluated, aged 63 ± 14 years, 61% male and GRACE score of 119 ± 37. Obstructive coronary disease was observed in 81% of the patients, classified as one, two or three vessel disease, or left main coronary artery involvement in 28%, 23%, 26% and 4%, respectively. The area under the ROC curve of the GRACE score was 0.65 (95% CI = 0.61 - 0.69) for predicting severe disease. The cutoff point below which the first GRACE tertile is defined (109) was used to dichotomize low-risk (N = 318) and medium-high-risk (N = 415) samples. This standard definition of intermediate-high risk by the GRACE score (> 109) revealed sensitivity of 67% in detecting severe anatomy (95% CI = 61% - 72%) and specificity of 50% (95% CI = 46% - 55%), resulting in positive likelihood ratio of 1.3 (95% CI = 1.2 - 1.5) and negative likelihood ratio of 0.66 (95% CI = 0.55 - 0.80). There was a weak correlation between GRACE and anatomical scores such as SYNTAX (r = 0.36, P < 0.001) and Gensini (r = 0.36, P < 0.001). Conclusion Despite statistical association with extent of anatomical coronary disease, the GRACE Score is not accurate to predict severity of disease before coronary angiography.

22 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AMAndré Costa Meireles
André Costa Meireles
JOJoão Vítor Miranda Porto de Oliveira
João Vítor Miranda Porto de Oliveira
BPBruna de Sá Barreto Pontes
Bruna de Sá Barreto Pontes
ASAlexandre Costa Souza
Alexandre Costa Souza
LGLaila Caroline Oliveira Souza Barbosa Gomes
Laila Caroline Oliveira Souza Barbosa Gomes
LCLuis Claudio Lemos Correia
Luis Claudio Lemos Correia
Background: Despite the presence of clinical, laboratory and electrocardiographic characteristics suggestive of acute pericarditis, there is no multivariate diagnostic score developed for this condition. Objective: To develop a clinical score for diagnosis of pericarditis as the cause of acute chest pain, using data from admission. Methods: In a diagnostic case-control study, we compared consecutive 45 patients of the Chest Pain Registry diagnosed of pericarditis (confirmed by magnetic resonance imaging or the presence of pleural effusion in echocardiography) versus 90 patients with an alternative confirmed diagnosis, randomly selected from our registry. Six clinical characteristics, 16 chest pain characteristics and 4 additional tests were candidates as predictors. Logistic regression was used to derivate a model composed by independent predictors of pericarditis. Results: Among 17 variables associated with pericarditis, 5 remained independent predictors: age; pain aggravation with thorax movement; positive troponin; diffuse ST-segment elevation and C-reactive protein. Each independent predictor was attributed points proportional to its regression coefficient. The final score presented discriminatory capacity represented by C-statistic of 0.97 (95% CI = 0.93 – 1.0). The best cutoff point was defined as > 6 points, with sensitivity of 96% (95% CI = 85 – 100), specificity of 87% (95% CI = 78 – 93), positive likelihood ratio of 7.2 (95% CI = 4.2 – 12) and negative likelihood ratio of 0.05 (95% CI = 0.01 – 0.2). Conclusion: The proposed multivariate score seems to be accurate for the diagnosis of pericarditis and require further validation in an independent sample.